Physician profile
Bryan Kirby
NPI 1518183789
$6,608.01
in general payments reported to CMS, 2019-2025
36 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $382 · 2021: $1,044 · 2022: $282 · 2023: $588 · 2024: $2,485 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,134 · Travel and Lodging: $1,088 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,133.89 |
| Travel and Lodging | $1,088.20 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,228.86 | 2021-2024 | Augment Injectable, Insignia |
| Medtronic, INC. | $884.19 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Abbott Laboratories | $787.32 | 2019-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $417.63 | 2020-2024 | |
| Nevro Corp. | $369.51 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $347.15 | 2020-2025 | Sprint Pns System |
| Globus Medical, INC. | $255.77 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $213.82 | 2019-2024 | Mild Device Kit |
| Dynasplint Systems INC. | $194.67 | 2021 | |
| Collegium Pharmaceutical, INC. | $185.48 | 2022-2024 | Belbuca, Xtampza |
| Pacira Therapeutics, INC. | $169.28 | 2019-2021 | |
| Abbvie INC. | $165.71 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $145.02 | 2024-2025 | |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Mml US, INC. | $134.35 | 2025 | Reactiv8 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $127.16 | 2019-2022 | |
| Heron Therapeutics, INC. | $122.96 | 2021-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $110.95 | 2020-2025 | Exparel, Zilretta, Iovera |
| Biodelivery Sciences International, INC. | $86.09 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $73.52 | 2019-2020 | |
| Saluda Medical Americas, INC. | $68.22 | 2022-2023 | Evoke Scs |
| Tersera Therapeutics LLC | $61.64 | 2019-2023 | Prialt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.83 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $37.85 | 2019-2022 | |
| Avanos Medical | $33.11 | 2022-2025 | Standard Rf Disposables |
| Mdd US Operations, LLC | $32.44 | 2019 | |
| Ethicon US, LLC | $29.11 | 2024 | Ethicon, Vistaseal, Dermabond Prineo |
| Zyla Life Sciences, INC. | $28.07 | 2020 | |
| Medline Industries LP | $21.66 | 2025 | |
| Si-Bone, INC. | $17.92 | 2020 | |
| Merck Sharp & Dohme LLC | $14.11 | 2025 | |
| Acera Surgical, INC. | $14.07 | 2019 | |
| Curonix LLC | $13.72 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $13.69 | 2024 | Hymovis |
| Heraeus Medical, LLC. | $12.70 | 2019 | |
| Polarityte, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.